LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib.
Clinical trial NCT02450903 · COMPLETED
Trial details
- NCT number
- NCT02450903
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-21
- Primary completion
- 2017-07-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.